Author

R. Ansari

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

D. A. Jackson· 2 shared E. Goncalves· 2 shared A. Barthorpe· 1 shared A. Beck· 1 shared C. Beaver· 1 shared C. Buser-Doepner· 1 shared C. Hall· 1 shared C. M. Beaver· 1 shared

Activity by Year

2018-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. A. Jackson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A suspension technique for efficient large-scale cancer organoid culturing and perturbation screens

S. Price, S. G. Bhosle, E. Goncalves, X. Li, D. McClurg, A. Barthorpe, A. Beck, C. Hall, H. Lightfoot, L. Farrow, R. Ansari, D. A. Jackson, L. Allen, K. Roberts, C. Beaver, , M. Garnett

This paper introduces a suspension culture technique for cancer organoids that improves expansion efficiency and enables large-scale perturbation screens.

bioRxiv · Oct 23, 2021Cancer Biology

Prioritisation of oncology therapeutic targets using CRISPR-Cas9 screening

F. M. Behan, F. Iorio, E. Goncalves, G. Picco, C. M. Beaver, R. Santos, Y. Rao, R. Ansari, S. Harper, D. A. Jackson, R. McRae, R. Pooley, P. Wilkinson, D. Dow, C. Buser-Doepner, , G. J. Mathew

This study uses CRISPR-Cas9 screens in cancer cell lines to identify and prioritize new oncology therapeutic targets based on gene fitness, biomarkers, and tractability.

bioRxiv · Dec 20, 2018Cancer Biology